Cargando…
Anoctamins and Calcium Signalling: An Obstacle to EGFR Targeted Therapy in Glioblastoma?
SIMPLE SUMMARY: Glioblastoma is the most lethal form of brain cancer in adults. No new successful treatments have been developed in 30 years and survival rates have not improved, primarily because of a lack of effective drug treatments. Up to 60% of glioblastoma tumours have increased activity of a...
Autores principales: | Dewdney, Brittany, Ursich, Lauren, Fletcher, Emily V., Johns, Terrance G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740065/ https://www.ncbi.nlm.nih.gov/pubmed/36497413 http://dx.doi.org/10.3390/cancers14235932 |
Ejemplares similares
-
From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress
por: Dewdney, Brittany, et al.
Publicado: (2023) -
Calmodulin-dependent activation and inactivation of anoctamin calcium-gated chloride channels
por: Vocke, Kerstin, et al.
Publicado: (2013) -
Glioblastoma — treatment and obstacles
por: Cantidio, Farley Soares, et al.
Publicado: (2022) -
Differentiation therapy for glioblastoma – too many obstacles?
por: Carén, Helena, et al.
Publicado: (2015) -
Channel properties of the splicing isoforms of the olfactory calcium-activated chloride channel Anoctamin 2
por: Ponissery Saidu, Samsudeen, et al.
Publicado: (2014)